Secondary Logo

Journal Logo

Articles by John P. Neoptolemos, FRCS

The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma

Ghaneh, Paula; Kleeff, Jorg; Halloran, Christopher M.; More

Annals of Surgery. 269(3):520-529, March 2019.

Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial

Tatarian, Talar; Jiang, Wei; Leiby, Benjamin E.; More

Annals of Surgery. 267(2):364-369, February 2018.

Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery

Sabater, Luis; Ausania, Fabio; Bakker, Olaf J.; More

Annals of Surgery. 264(6):949-958, December 2016.

Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis

Gomatos, Ilias P.; Halloran, Christopher M.; Ghaneh, Paula; More

Annals of Surgery. 263(5):992-1001, May 2016.

Minimal Access Retroperitoneal Pancreatic Necrosectomy: Improvement in Morbidity and Mortality With a Less Invasive Approach

Raraty, Michael G. T.; Halloran, Christopher M.; Dodd, Susanna; More

Annals of Surgery. 251(5):787-793, May 2010.

Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial

Neoptolemos, John P.; Stocken, Deborah D.; Dunn, Janet A.; More

Annals of Surgery. 234(6):758-768, December 2001.